Simcyp Discovery Simulator
Tailored for discovery and translational scientists, Simcyp Discovery Simulator is an intuitive software that delivers…
Certara2022 年 7 月 14 日
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
PRINCETON, N.J.— 2022 年 7 月 12 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today…
Certara2022 年 7 月 12 日
Highlights from the FDA-ASCO Workshop on Dose Optimization for Oncology Drugs
The FDA-ASCO (American Society of Clinical Oncology) workshop on oncology dose optimization (3-5 May 2022)…
Certara2022 年 7 月 8 日
Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey
Cell therapies aim to treat, prevent, or potentially cure diseases. They are a relatively new…
Certara2022 年 7 月 8 日
Why FDA’s New Guidance on Circulating Tumor DNA is Critical for Oncology Early Clinical Drug Development
2022 is shaping up to be the “year of the guidance” as the FDA has…
Certara2022 年 7 月 1 日
Axendia: Improving Healthcare Outcomes by Rewarding Value, NOT Cost
This research examines the use of value-based communications to support the transition to fee-for-outcomes models…
Certara2022 年 6 月 28 日
Certara’s Simcyp Discovery Demo
View this software demo by Dr. Hannah Jones to learn about how Simcyp Discovery provides…
Certara2022 年 6 月 28 日
Utilizing Pharmacokinetic and Pharmacodynamic Modeling & Simulation Technologies for Anesthesiology and Pain Medicine
Today, we are interviewing Professor Gyujeong Noh from Anesthesiology and Pain Medicine/Clinical Pharmacology and Therapeutics…
Certara2022 年 6 月 17 日
